XYMOGEN announced recently that it has been awarded a prestigious certification from Australia's Therapeutic Goods Administration (TGA).
The TGA is Australia’s equivalent to the U.S. Food and Drug Administration (FDA).
The TGA certification is recognized for having the most demanding good manufacturing practices (GMP) audit processes in the dietary supplement industry in the world. The set of standards employed by the TGA are similar to the GMP requirements on the pharmaceutical level. XYMOGEN spent two years working to earn the certification.
In accordance with the rigorous TGA requirements, XYMOGEN has to demonstrate stringent obedience to manufacturing and quality standards and practices. The TGA standards surpass even those put into place by the FDA.
The certification is a validation of XYMOGEN’s goals and commitment to developing the highest quality of dietary supplements. It shows that the company has maintained a strong level of standards in the manufacturing of its products.
Brian Blackburn, founder and CEO of XYMOGEN, stated that it took a joint collaboration of every department in XYMOGEN’s manufacturing company to achieve the prestigious certification.